However, a composite endpoint of biopsy-proven AMR, graft loss, patient death, or loss to follow-up at week 9 post-transplant did not reach statistical significance.
1
—
—
However, a composite endpoint of biopsy-proven AMR, graft loss, patient death, or loss to follow-up at week 9 post-transplant did not reach statistical significance.